Novartis Willful Patent Infringement Claims Dismissed In New York
Mealey's (October 26, 2018, 11:05 AM EDT) -- NEW YORK — A New York federal judge on Oct. 24 found that allegations of willful infringement levied in connection with patented gene expression technology fail to state a claim (Novartis...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login